Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daridorexant DDI with Dabigatran and Rosuvastatin in Healthy Males
NCT05480475Phase 1Completed
- Sponsor
- Idorsia
- Start
- Sep 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of daridorexant in Insomnia, sponsored by Idorsia. Primary endpoint: Maximum Plasma Concentration. Started Sep 2022; status: completed.
02
Drugs
daridorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT05480475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05480475.